Way more to IHL that as someone earlier suggest re cannabis being dead. That is so far off the mark that you have to wonder.
"Impression Healthcare’s (ASX: IHL) dronabinol project has taken on anther dimension after the company signed a memorandum of understanding and exclusivity agreement with RespireRx Pharmaceuticals.Dronabinol was the first ever cannabinoid medicine permitted for patient use by the Food and Drug Administration in the United States and a synthetic dronabinol has been marketed under the trade name Marinol since in 1986.The deal means Impression has the right to licence, partner, or complete a joint venture over proprietary information associated with completed phase 2 clinical trials for the use of dronabinol to treat obstructive sleep apnoea. Sleep apnoea is a serious sleep disorder that is characterised by interrupted breathing during sleep."
This is a game changer and globally significant issue. Look at Paincheck (PCK) for Australian innovation in game changing medicine., Not cross promoting but an example of significant medical treatment for global issues. What do we think stopping the requirement for CPAP machines is worth to a sufferer? How big a market? Massive.
